Core Points - The controlling shareholder of Xi'an Kanghui Pharmaceutical Co., Ltd. will change to Yuehe Zhichuang after the completion of the share transfer and related governance adjustments [1][2] - The share transfer involves 21,973,600 shares, representing 22% of the total shares, at a price of RMB 24.70 per share [1][2] - The actual controllers will be Li Hongming and Wang Xuefang after the governance adjustments are completed [2][3] Share Transfer Details - The share transfer has been completed, with the shares transferred to Yuehe Zhichuang on July 8, 2025 [2] - Before the transfer, Kanghui Holdings held 36,706,237 shares (36.75%), which will reduce to 14,732,637 shares (14.75%) after the transfer [2] - Yuehe Zhichuang will hold 21,973,600 shares (22%) post-transfer [2] Governance Changes - The company will proceed with the adjustment of board members and the appointment of executives as per the supplementary agreement [2][3] - The final implementation of the governance changes remains uncertain until the adjustments are completed [3]

陕西康惠制药股份有限公司 证券代码：603139 证券简称：康惠制药 公告编号：2025-040 近日，康惠控股与悦合智创就本次股份转让已办理完成相关过户登记手续， 并取得了中国证券登记结算有限责任公司上海分公司出具的《证券过户登记确认 书》，康惠控股所持有的公司无限售条件流通股 21,973,600 股股份已过户登记至 悦合智创名下，过户日期为 2025 年 7 月 8 日。 关于控股股东协议转让公司股份完成过户登记 暨控制权拟发生变更的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 本次权益变动相关事项已在中国证券登记结算有限责任公司上海分公司 办理完毕股份过户登记手续。 本次权益变动事项尚待进行公司治理事宜调整，待公司治理事宜调整完 毕之日起，公司控股股东将变更为悦合智创，实际控制人将变更为李红明、王雪 芳夫妇，前述事项的最终实施结果尚存在不确定性，敬请投资者注意投资风险。 一、本次权益变动情况概述 2025 年 3 月 20 日, 陕西康惠制药股份有限公司（以下简称"康惠制药"、"上 市公司"） ...

Group 1 - *ST San Sheng (002742.SZ): The controlling shareholder Pan Xianwen's 32.2 million shares have been transferred, accounting for 7.30% of the total share capital, reducing his holding from 17.26% to 16.75, with no change in company control [1] - Aikang Co., Ltd. (300889.SZ): Shareholders Zhang Fengbin and Feng Renrong reduced their holdings by a total of 1.76 million shares, accounting for 1.06% of the total share capital, completing the reduction plan [1] - Allianz Ruishi (301042.SZ): Director Shen Lei reduced his holdings by 98,700 shares, accounting for 0.14% of the total share capital, with the reduction plan period ending [1] Group 2 - Baotong Technology (300031.SZ): Controlling shareholder Bao Zhifang and director Tang Yu plan to reduce their holdings by up to 8.3749 million shares and 1.526988 million shares, accounting for no more than 2% and 0.36% of the total share capital, respectively [2] - Biyiwei (688045.SH): Shareholders Fang Guang Erqi and Yuan Chengjun plan to reduce their holdings by up to 139,680 shares and 69,840 shares, accounting for no more than 2% and 1% of the total share capital, respectively [2] - Chahua Co., Ltd. (603615.SH): Shareholder Shenzhen Hanjinliang reduced 2.397 million shares, accounting for 0.99% of the total share capital, completing the reduction plan [2] Group 3 - Dacai Co., Ltd. (605287.SH): Shareholder Qingdao Dikuang Chanquan Development Co., Ltd. reduced 3.64 million shares, accounting for 2.60% of the total share capital, completing the reduction plan [3] - Dize Pharmaceutical (688192.SH): Vice President Zhang Shiying reduced 161,550 shares, accounting for 0.0035% of the total share capital, completing the reduction plan [3] - Fuhan Micro (300613.SZ): Controlling shareholder's concerted action party plans to reduce up to 6.90208 million shares, accounting for 3% of the total share capital [3] Group 4 - Guanghuan Xinwang (300383.SZ): Directors and vice presidents plan to reduce a total of up to 720,476 shares, accounting for no more than 0.04% of the total share capital [4] - Hanyu Group (300403.SZ): Director and Vice President Wu Geming plans to reduce up to 1 million shares, accounting for 0.1658% of the total share capital [4] - Haosen Intelligent (688529.SH): Shareholders plan to reduce a total of up to 3 million shares, accounting for 1.7838% of the total share capital [4] Group 5 - Huilong New Materials (301057.SZ): Controlling shareholder's concerted action party plans to reduce up to 3.482902 million shares, accounting for 3% of the total share capital excluding repurchased shares [5] - Huitong Co., Ltd. (688219.SH): Shareholder Tong'an Fund reduced 4.667815 million shares, accounting for 0.93% of the total share capital, completing the reduction plan [5] Group 6 - Jiangsu Shentong (002438.SZ): Shareholder Huzhou Fenglin Huoshan Equity Investment Partnership reduced a total of 14.205 million shares, accounting for 2.798808% of the total share capital, completing the reduction plan [6] - Jiangtian Chemical (300927.SZ): Shareholder Jiangshan Co., Ltd. reduced 1.3265 million shares, accounting for 0.92% of the total share capital [6] - Jin Sanjiang (301059.SZ): Shareholder Guangzhou Saina reduced 104,900 shares, accounting for 0.05% of the total share capital, completing the reduction plan [6] Group 7 - Jingxue Energy (301010.SZ): Controlling shareholder's concerted action party reduced 1.08 million shares, accounting for 1% of the total share capital, completing the reduction plan [7] - Jiuwu High-Tech (300631.SZ): Vice President Wang Xiaohu and Cheng Junjun plan to reduce up to 18,900 shares and 5,000 shares, accounting for no more than 0.1511% and 0.04% of the total share capital, respectively [7] - Kanghui Pharmaceutical (603139.SH): Shareholder Shanghai Sailoxian plans to reduce up to 2.9964 million shares, accounting for 3% of the total share capital [7] Group 8 - Meino Biological (301156.SZ): Shareholder's concerted action party reduced 1.297029 million shares, accounting for 0.92% of the total share capital, completing the reduction plan [8] - Minfa Aluminum Industry (002578.SZ): Shareholder Huang Tianhuo reduced 6.6702 million shares, accounting for 0.71% of the total share capital, reducing his holding to 4.9963% [8] - Nuo Puxin (002215.SZ): Directors and senior management plan to reduce a total of up to 1.8607 million shares, accounting for no more than 0.185% of the total share capital [8] Group 9 - Entropy Technology (301330.SZ): Shareholders reduced a total of 4,693,864 shares, accounting for 1.9556% of the total share capital, completing the reduction plan [9] - Shengbang Co., Ltd. (301233.SZ): Supervisor Hu Jilin plans to reduce up to 5,650 shares, accounting for 0.0111% of the total share capital [9] - Shudao Equipment (300540.SZ): Senior management did not reduce their shares, and the reduction plan period has ended [9] Group 10 - Tongyu Communications (002792.SZ): Controlling shareholder and actual controller Shi Guiqing plans to reduce up to 15,653,487 shares, accounting for 2.9963% of the total share capital [10] Group 11 - Wuzhou Xinchun (603667.SH): Senior management plans to reduce a total of up to 22,500 shares, accounting for no more than 0.0061%, 0.0067%, and 0.0037% of the total share capital [11] - New Sharp Co., Ltd. (688257.SH): Senior management plans to reduce up to 750,000 shares, accounting for no more than 0.2971% of the total share capital [11] - New Hope (000876.SZ): Senior management reduced 225,000 shares, accounting for 0.005% of the total share capital, completing the reduction plan [11] Group 12 - Youke De (688158.SH): Shareholder Zhongyi Capital reduced 882,766 shares, accounting for 0.19% of the total share capital, completing the reduction plan [12] - Changqing Technology (001324.SZ): Shareholders reduced a total of 4,165,050 shares, accounting for 3.00% of the total share capital, completing the reduction plan [12] - Changxin Bochuang (300548.SZ): Shareholders plan to reduce up to 8.6 million shares, accounting for 2.95% of the total share capital [12] Group 13 - Zhongfu Industrial (600595.SH): Shareholder Henan Yicheng Chuangtou plans to reduce up to 40 million shares, accounting for 1% of the total share capital [13] - Zhuhai Ming Technology (300232.SZ): Controlling shareholder Lin Mingfeng plans to reduce up to 21,722,009 shares, accounting for 1.99% of the total share capital [13] - Zhuoyi Information (688258.SH): Employee shareholding platform plans to reduce up to 2,271,445 shares, accounting for no more than 1.88% of the total share capital [13]

Market News - US stock indices collectively declined, with the Dow Jones down 0.94%, Nasdaq down 0.92%, and S&P 500 down 0.79%. The US will impose a 25% tariff on all products from Japan and South Korea starting August 1, leading to declines in stocks of Japanese and Korean companies listed in the US, such as Nissan down over 7% and Toyota down nearly 4% [1] - International oil prices surged, with US crude oil main contract up 1.37% to $67.92 per barrel, and Brent crude oil main contract up 1.84% to $69.56 per barrel. International precious metal futures closed mixed, with COMEX gold futures up 0.10% to $3346.40 per ounce, while COMEX silver futures down 0.39% to $36.94 per ounce [1] Industry Insights - The Hong Kong Securities and Futures Commission held a meeting discussing the regulation of virtual asset trading platforms, focusing on the ASPIRe roadmap's pillars A (Access) and P (Products). The Financial Secretary indicated that guidelines on anti-money laundering and other requirements will be published this month, with a limited number of stablecoin licenses expected [2] - TrendForce reported that the transition from older DRAM products to new generations will occur in Q3, with demand expected to rise due to traditional peak season and EOL announcements from major manufacturers. Overall memory prices are projected to increase by 15-20%, with DDR4 prices potentially rising by 38%-45% [3] - The National Development and Reform Commission announced plans for the scientific planning and construction of high-power charging facilities, aiming for over 100,000 such facilities by the end of 2027. This aligns with the growing electric vehicle market, with China projected to hold 58% of the global electric vehicle stock by 2025 [4][5]

Summary of Key Points Core Viewpoint - The announcement details a share reduction plan by a major shareholder, Shanghai Sailoxian Enterprise Management Consulting Co., Ltd., which holds 4% of the total shares of Xi'an Kanghui Pharmaceutical Co., Ltd. The plan involves reducing up to 2,996,400 shares, representing 3% of the company's total shares, over a specified period. Group 1: Shareholder Information - The shareholder, Shanghai Sailoxian, holds 3,995,200 shares, accounting for 4% of the total share capital of the company [1][2] - The shares were acquired through an agreement transfer [2] Group 2: Reduction Plan Details - The reduction plan allows for a maximum of 2,996,400 shares to be sold, which is up to 3% of the total shares [1][2] - The reduction will occur through two methods: a maximum of 998,800 shares via centralized bidding and up to 1,997,600 shares through block trading [2] - The planned reduction period is from July 29, 2025, to October 26, 2025 [2] Group 3: Purpose and Conditions - The reason for the reduction is stated as necessary for the shareholder's own business development plans [2] - The implementation of the reduction plan is subject to market conditions and the company's stock price [2][3]

Core Viewpoint - Several listed companies in the Shanghai and Shenzhen markets have announced significant developments, including management changes, stock trading fluctuations, and major contracts, which may present investment opportunities and risks for investors [2]. Group 1: Management Changes and Legal Issues - Scanda's chairman and general manager, Li Yuejie, along with director Zhu Chuncheng, have been subjected to criminal coercive measures due to alleged violations related to information disclosure [3]. - Longhong High-Tech is planning to acquire 100% equity of Guangxi Changke, leading to a stock suspension for up to 10 trading days [6]. Group 2: Stock Trading and Performance - New Asia Electronics reported abnormal stock trading with a cumulative price deviation exceeding 20% over three days, while confirming that its operations are normal and consistent with previously disclosed share reduction plans [5]. - ST Tiexin announced the removal of risk warnings and a name change, which will increase the trading limit from 5% to 10% [8]. Group 3: Financial Performance Forecasts - Industrial Fulian expects a net profit increase of 36.84% to 39.12% year-on-year for the first half of 2025, driven by a surge in AI-related business [18]. - Huayou Cobalt anticipates a net profit increase of 55.62% to 67.59% for the same period, benefiting from integrated operations and rising cobalt prices [19]. - Guoli Co. forecasts a staggering net profit increase of 130.91% to 158.08% for the first half of 2025, attributed to new product and market expansions [20]. - Bangji Technology expects a net profit increase of 166.77% to 200.91%, driven by increased sales from direct sales channels [21]. - Lier Chemical predicts a net profit increase of 185.24% to 196% due to rising product sales and cost reduction efforts [25]. Group 4: Major Contracts and Projects - Huadian Science and Technology signed significant contracts worth approximately RMB 25.16 billion for coal handling and transportation systems [41]. - Aerospace Engineering is the first candidate for a project with a bid of RMB 23.92 billion for a coal gasification facility [43].

Group 1 - The People's Bank of China has increased its gold reserves for the eighth consecutive month, reaching 73.9 million ounces by the end of June, up from 73.83 million ounces at the end of May, indicating a bullish outlook for gold prices in the second half of the year due to various economic factors [1] - The Chinese government aims to promote the construction of over 100,000 high-power charging facilities by the end of 2027, which is expected to enhance the value and profit margins of the charging pile industry [3] - Longxin Technology Group has initiated the listing guidance process for its IPO, focusing on the development, design, production, and sales of DRAM products, with a registered capital of approximately 60.193 billion yuan [7] Group 2 - The A-share market saw a decrease in trading volume, with a total turnover of 1.23 trillion yuan, down 227.5 billion yuan from the previous day, marking the lowest level in nearly two weeks [5] - The implementation of new regulations on quantitative trading is expected to significantly impact high-frequency trading strategies, leading to a structural differentiation within the industry [8] - The domestic sales of quadruped robots are projected to reach 394,800 units by 2031, representing an almost eightfold increase compared to 2025, driven by advancements in AI technology [15]

Group 1 - Longte Intelligent's wholly-owned subsidiary plans to establish a private equity investment fund focusing on low-altitude economy and embodied intelligence industry chain with a total investment of 15 million RMB [1] - Huadian Technology signed significant contracts totaling approximately 5.567 billion RMB, which includes design supply and construction contracts for the Nusantara project [2] - Shanghai Xiba plans to participate in the auction for Yuyuan Rare Earth's lithium sulfide business assets to promote development in the new energy sector [3] Group 2 - Lens Technology has set the final price for its H-share issuance at 18.18 HKD per share, with expected listing on July 9, 2025 [4] - Yiling Pharmaceutical received approval for clinical trials of its new drug "G201-Na capsule," aimed at controlling ovulation in assisted reproductive technology [5] - Chendian International announced that the adjustment of the time-of-use electricity pricing mechanism will have a slight impact on its electricity business revenue, with a preliminary estimate of an increase of 382,000 RMB [6] Group 3 - Ruiskanda's chairman and general manager are under criminal coercive measures for suspected violations related to information disclosure [7] - Changhong High-Tech is planning to acquire 100% equity of Guangxi Changke New Materials Co., Ltd., with stock suspension expected for up to 10 trading days [8] Group 4 - Aerospace Engineering is expected to win a project worth 2.392 billion RMB [9] - Several companies, including Xianggang Technology and Yinglian Co., are forecasting significant increases in net profits for the first half of the year, with growth rates ranging from 185% to 478% [10]

7月7日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者参 考。 【品大事】 斯康达：公司董事长兼总经理李月杰和董事朱春城被采取刑事强制措施 工业富联二季度净利润预增约五成 工业富联(601138)发布2025年半年度业绩预告，预计上半年实现归母净利润119.58亿元—121.58亿元， 同比上升36.84%到39.12%；预计第二季度实现归母净利润67.27亿元到69.27亿元，同比上升47.72%— 52.11%，均创下同期历史新高。业绩大幅增长主要得益于AI相关业务的爆发，在第二季度AI服务器营 收同比增长超过60%，800G交换机营收达2024全年的3倍。 华友钴业：上半年净利同比预增55.62%到67.59% 瑞斯康达(603803)公告，7月5日，公司收到相关人员家属通知，因涉嫌违规披露、不披露重要信息罪， 根据《中华人民共和国刑事诉讼法》第八十二条的规定，北京市公安局朝阳分局决定对公司董事长兼总 经理李月杰和董事朱春城采取刑事强制措施，其中朱春城已被取保候审。经与有关部门了解，上述涉嫌 违规披露、不披露重要信息事项与2023年9月中国证监会对公司做出的行政处罚系同 ...

证券代码：603139 证券简称：康惠制药 公告编号：2025-039 陕西康惠制药股份有限公司 关于股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东持股的基本情况：截止本公告披露日，陕西康惠制药股份有限公 司 （以下简称"公司"）股东上海赛乐仙企业管理咨询有限公司（以下简称"赛乐 仙"）持有公司无限售条件流通股 3,995,200 股股票，占公司总股本 4%。 减持计划的主要内容：赛乐仙计划自本公告披露之日起十五个交易日 后的三个月内，以集中竞价及大宗交易方式合计减持股份总数不超过 2,996,400 股（即合计不超过公司股份总数的 3%），减持价格依据市场价格确定。采取集中 竞价交易方式减持公司股份的，任意连续 90 个自然日内，减持股份的总数不超 过公司总股本的 1%；采取大宗交易方式减持公司股份的，任意连续 90 个自然日 内，减持股份的总数不超过公司总股本的 2%；若此期间有送股、资本公积转增 股本等股份变动事项，则对应数量进行相应调整。 2025 年 7 月 7 ...